28 results
8-K
EX-99.1
RNLX
Renalytix Plc
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
to external R&D projects and studies with Mount Sinai, Wake Forest and Joslin, a decrease of $0.3 million in compensation and related benefits
8-K
RNLX
Renalytix Plc
29 Feb 24
Regulation FD Disclosure
6:05am
Forest University School of Medicine; and
Dr. Joji Tokita, MD, Nephrologist and Associate Professor of Medicine at the Icahn School of Medicine at Mount … patients from the Mount Sinai Health System and the Atrium/Wake Forest Health System who are being treated based on their initial risk assessment
8-K
EX-99.1
RNLX
Renalytix Plc
15 Feb 24
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
7:00am
, Wake Forest and Joslin.
General and administrative expenses were $5.3 million for the three months ended December 31, 2023, decreasing by $1.5
10-Q
0njrz2pc7o8ikj0
14 Nov 23
Quarterly report
12:00am
8-K
EX-99.1
mjco0f
14 Nov 23
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
12:00am
8-K
EX-99.1
g9rkzuj
28 Sep 23
Renalytix Reports Full Year Fiscal 2023 Results
7:31am
10-K
j73mj1o40lzcfj
28 Sep 23
Annual report
6:18am
6-K
yczv vmuf6
30 Mar 23
Current report (foreign)
7:01am
6-K
kd47v 5fq41
30 Nov 22
Current report (foreign)
7:31am
6-K
EX-99.1
hvn915270k tpspvz2ex
22 Nov 22
Annual Report and For the Year Ended 30 June 2022
5:09pm
POS AM
nxdft5
1 Aug 22
Prospectus update (post-effective amendment)
4:57pm
6-K
5r2b3ia fqgnucz00okg
30 Jun 22
Current report (foreign)
7:01am
424B3
q8yxw
6 Jun 22
Prospectus supplement
4:31pm
F-3
b3te0
27 May 22
Shelf registration (foreign)
4:06pm
6-K/A
topgr
29 Apr 22
Current report (foreign) (amended)
4:58pm
6-K
EX-99.1
cf5tx svvjs
31 Mar 22
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022
7:00am
6-K
EX-99.1
qqoezlfpskl
7 Dec 21
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022
4:05pm